Skip to content

Biomarkers of Chronic Obstructive Pulmonary Disease

Specific Biomarker Identification of Different Subgroups of Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04963023
Acronym
BIOBPCO
Enrollment
75
Registered
2021-07-15
Start date
2021-06-15
Completion date
2023-07-01
Last updated
2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Asthma-COPD Overlap Syndrome, COPD

Keywords

COPD, Asthma-COPD Overlap Syndrome, Asthma

Brief summary

There are few studies about immunological explorations in COPD. Because of the complications of lung biopsies, analyses are generally made on blood samples instead of lung tissue. No study tried to classify COPD vs Asthma vs ACOS. The investigators wondered if there were differences in biomarkers between these groups. The investigators decided to open a pilot-study among COPD patients followed in Amiens-University Hospital. Each patient will be examined and a blood-test will be performed.

Interventions

BPCO physical examinations

DIAGNOSTIC_TESTblood test

blood test in order to study immunologic markers

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BPCO patients * ACOS patients * asthmatic patient without BPCO

Exclusion criteria

* infection * exacerbation * immunosuppressive treatment * immunosuppressive disease

Design outcomes

Primary

MeasureTime frameDescription
identification specific blood immunologic marker for COPDone hourCOPD biomarkers are blood immunologic markers

Secondary

MeasureTime frame
Complete blood count (CBC) Variation between COPD and asthmatic patientsone hour
c-reactive protein concentration variation between COPD and asthmatic patientsone hour
Plasma protein electrophoresis profile Variation between COPD and asthmatic patientsone hour

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026